Her primary areas of study are Internal medicine, COPD, Pulmonary hypertension, Cardiology and Respiratory disease. Her Internal medicine study integrates concerns from other disciplines, such as Endocrinology and Surgery. Her research integrates issues of Ventilation/perfusion ratio, Breathing, Pathology, Skeletal muscle and Physical exercise in her study of COPD.
Her Pulmonary hypertension research incorporates elements of Anesthesia, Hypoxia, Heart failure and Intensive care medicine. Her Cardiology research integrates issues from Respiratory minute volume and Obstructive lung disease. The study incorporates disciplines such as Systemic inflammation, Thorax, Quality of life and Pulmonary artery in addition to Respiratory disease.
Joan Albert Barberà mainly investigates Internal medicine, Pulmonary hypertension, COPD, Cardiology and Pathology. Her work deals with themes such as Endocrinology and Surgery, which intersect with Internal medicine. Her Pulmonary hypertension study incorporates themes from Hemodynamics, Vascular resistance, Pulmonary artery and Endothelial dysfunction.
Her COPD research includes elements of Pulmonary disease, Immunology, Lung, Pulmonary function testing and Endothelium. Her Pathology study frequently draws parallels with other fields, such as Progenitor cell. Her Respiratory system research focuses on Anesthesia and how it connects with Bronchodilator.
Joan Albert Barberà focuses on Internal medicine, Pulmonary hypertension, Cardiology, In patient and COPD. Her Internal medicine study frequently links to adjacent areas such as Gastroenterology. Her studies deal with areas such as Inflammation, Intensive care medicine, Idiopathic pulmonary fibrosis, Lung and Pharmacology as well as Pulmonary hypertension.
Her research on Cardiology often connects related areas such as Therapeutic approach. Her COPD research is multidisciplinary, incorporating elements of DLCO, Endothelial dysfunction, Gene signature, Complication and Animal model. Joan Albert Barberà has included themes like Arterial stiffness and Vascular disease in her Pulmonary artery study.
The scientist’s investigation covers issues in Internal medicine, Pulmonary hypertension, Hazard ratio, Confidence interval and Cardiology. Her biological study spans a wide range of topics, including Lesion and Placebo. Her Pulmonary hypertension research includes themes of Hemodynamics, COPD, Pulmonary hemodynamics and Intensive care medicine.
Her COPD research is multidisciplinary, relying on both Guanylate cyclase, Animal model, Stimulation and Therapeutic effect, Pharmacology. She has researched Hazard ratio in several fields, including Ambrisentan, Tadalafil and Adverse effect. Her study on Myocardial infarction and Pulmonary embolism is often connected to ADAMTS13 and Endarterectomy as part of broader study in Cardiology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Guidelines for the diagnosis and treatment of pulmonary hypertension
Marius M. Hoeper;Marc Humbert;Adam Torbicki;Jean-Luc Vachiery.
European Respiratory Journal (2009)
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
Nazzareno Galiè;Joan A. Barberà;Adaani E. Frost;Hossein-Ardeschir Ghofrani.
The New England Journal of Medicine (2015)
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Results From an International Prospective Registry
Joanna Pepke-Zaba;Marion Delcroix;Irene Lang;Eckhard Mayer.
Circulation (2011)
Inflammation, growth factors, and pulmonary vascular remodeling.
Paul M. Hassoun;Luc Mouthon;Joan A. Barberà;Saadia Eddahibi.
Journal of the American College of Cardiology (2009)
Pulmonary hypertension in chronic obstructive pulmonary disease
J A Barberà;V I Peinado;S Santos.
European Respiratory Journal (2003)
Pulmonary hypertension due to left heart diseases.
Jean-Luc Vachiery;Yochai Adir;Joan Albert Barberà;Hunter C. Champion.
Journal of the American College of Cardiology (2013)
Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD
S. Santos;V.I. Peinado;J. Ramírez;T. Melgosa.
European Respiratory Journal (2002)
Pulmonary hypertension in chronic lung diseases
Werner Seeger;Werner Seeger;Yochai Adir;Joan Albert Barberà;Hunter Champion.
Journal of the American College of Cardiology (2013)
Diagnosis, Assessment, and Treatment of Non-Pulmonary Arterial Hypertension Pulmonary Hypertension
Marius M. Hoeper;Joan Albert Barberà;Richard N. Channick;Paul M. Hassoun.
Journal of the American College of Cardiology (2009)
Corrigendum to: ‘Guidelines for the diagnosis and treatment of pulmonary hypertension’ [European Heart Journal (2009) 30, 2493–2537]. The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)
Nazzareno Galiè;Marius M. Hoeper;Marc Humbert;Adam Torbicki.
European Heart Journal (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Barcelona
Hannover Medical School
University of Barcelona
University of Paris-Saclay
University of California, San Diego
Pompeu Fabra University
University of Paris-Saclay
University of Bologna
University of California, San Diego
University of Giessen
Google (United States)
Weizmann Institute of Science
Cleveland Clinic Lerner College of Medicine
South China University of Technology
Rice University
Osaka University
University of Western Australia
Miami University
Chinese Academy of Sciences
Public Health England
National Institutes of Health
Japan Agency for Marine-Earth Science and Technology
École Polytechnique Fédérale de Lausanne
Goethe University Frankfurt
University of California, Los Angeles
University of British Columbia